Expert Opinion on Therapeutic Targets

Papers
(The H4-Index of Expert Opinion on Therapeutic Targets is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Assessing platelet-derived extracellular vesicles for potential as therapeutic targets in cardiovascular diseases102
Endothelial dysfunction: a therapeutic target in bacterial sepsis?56
Scavenger receptor A in immunity and autoimmune diseases: Compelling evidence for targeted therapy46
Kidney and lipids: novel potential therapeutic targets for dyslipidemia in kidney disease?43
Targeting ALK receptors in non-small cell lung cancer: what is the road ahead?41
HIV Pol: does it offer therapeutic targets for HIV?35
Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancer35
Fatty liver disease: time to target CCR5?33
Ubiquitin-specific protease 7 (USP7): an emerging drug target for cancer treatment33
Retinal vein occlusion: drug targets and therapeutic implications33
Novel therapeutic targets for diabetes-related wounds or ulcers: an update on preclinical and clinical research31
Emerging therapeutic targets for narcolepsy30
Targeting VCAM-1: a therapeutic opportunity for vascular damage29
Dyskinesia and Parkinson’s disease: animal model, drug targets, and agents in preclinical testing28
IL-36: a therapeutic target for ulcerative colitis?28
An update on novel pharmacological agents for primary sclerosing cholangitis27
Glucocorticoid receptors participate in epilepsy in FCDII patients and MP model rats: A potential therapeutic target for epilepsy in patients with focal cortical dysplasia II (FCDII)27
Tolperisone induces UPR-mediated tumor inhibition and synergizes with proteasome inhibitor and immunotherapy by targeting LSD124
Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential24
The ATP-sensitive potassium channel: a therapeutic target for neurodegeneration?24
Calcium channelopathies in neurodegenerative disorder: an untold story of RyR and SERCA24
Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancer24
lncRNAs: potential therapeutic targets and biomarkers for pancreatic cancer?24
Advances in cerebellar disorders: pre-clinical models, therapeutic targets, and challenges24
0.1379280090332